Related Experiment Video
Updated: Dec 24, 2025

05:58
Tissue Triage and Freezing for Models of Skeletal Muscle Disease
Published on: July 15, 2014
41.1K
Consensus-Based Care Recommendations for Pulmonologists Treating Adults with Myotonic Dystrophy Type 1
Matthias Boentert1, Michelle Cao2, Daphne Mass3
1University Hospital Münster, Münster, Germany.
Respiration; International Review of Thoracic Diseases
|April 17, 2020
Summary
Myotonic dystrophy type 1 (DM1) is a progressive genetic disease causing respiratory failure. This consensus provides practical guidance for pulmonologists to improve respiratory care and reduce mortality in DM1 patients.
Area of Science:
- Neurology
- Pulmonology
- Genetics
Background:
- Myotonic dystrophy type 1 (DM1) is a severe genetic disorder affecting approximately 1 in 2,500 individuals globally.
- Respiratory muscle weakness is a common and progressive complication in DM1, often leading to respiratory failure and serving as a primary cause of mortality.
- Cardiac complications also frequently occur in DM1 patients.
Purpose of the Study:
- To provide pulmonologists, particularly those less experienced with DM1 or not part of a specialized neuromuscular clinic, with detailed diagnostic and management protocols.
- To outline respiratory testing and management strategies for baseline and follow-up care in DM1 patients.
- To adapt general respiratory knowledge to the specific challenges posed by this multiorgan disease.
Main Methods:
- A consensus-based approach was employed, involving a group of neuromuscular experts, including pulmonologists, respiratory physiotherapists, and sleep specialists.
- The Single Text Procedure methodology was utilized by 12 international respiratory therapists, pulmonologists, and neurologists experienced in DM respiratory care.
- The process generated a comprehensive document detailing respiratory care recommendations for managing DM1 patients, based on expert clinical experience.
Main Results:
- Consensus-based care recommendations were developed by 66 international clinicians experienced in DM1 treatment.
- A 7-page document providing detailed respiratory care recommendations for pulmonologists managing DM1 patients was created.
- The recommendations are based on expert opinion due to limited empirical evidence from clinical care data in DM patients.
Conclusions:
- The developed recommendations aim to enhance respiratory care for vulnerable DM1 patients.
- The guidance is intended to reduce the risk of respiratory complications and mortality associated with DM1.
- Practical indications for respiratory testing and management are provided to assist pulmonologists in caring for DM1 patients.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
2.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.6K
Cardiomyopathy V: Interprofessional Care
228
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
228
Myocarditis III: Medical Management
119
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
119
Cystic Fibrosis: Management
378
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
378
Chronic Obstructive Pulmonary Disease-V: Management
3.0K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.0K
Myocarditis IV: Nursing Management
158
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
158

